Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Single-center, Blinded Analysis Clinical Study to Evaluate the Safety and Efficacy of NT-88 in Patients With Heart Failure With Chronic Mildly Reduced Ejection Fraction

NCT07509801 is registered in ClinicalTrials.gov with Guangzhou Manjing biomedicine technology co., ltd as lead sponsor.

NCT NCT07509801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07509801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Single-center, Blinded Analysis Clinical Study to Evaluate the Safety and Efficacy of NT-88 in Patients With Heart Failure With Chronic Mildly Reduced Ejection Fraction
Lead sponsor
Guangzhou Manjing biomedicine technology co., ltd
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 30, 2026
Completion date
June 30, 2027
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with mildly reduced ejection fraction